Skip to main content Skip to section navigation Skip to footer
OPKO Health, Inc. Corporate homepage OPKO Health, Inc. Corporate homepage
  • Company
    • About Us
    • Team
    • Partner With Us
    • Careers
    • Contact
  • Pipeline
  • Science & Technology
    • ModeX Platforms
    • Long-Acting Biologics & Peptides
    • Publications
  • Global Pharmaceuticals
    • Our Medicines
    • Global Operations
  • Investors
    • Investors Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Governance
Site Announcement

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release
Visit BioReference Health

Press Releases

Investors

  • Investors Overview
  • News / Events
    • News / Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Information
    • Company Profile
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Chart
    • Historical Data
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • News / Events Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 8, 2014 9:26 am EDT
OPKO Announces Dismissal of PROLOR Biotech, Inc. Class Action Lawsuit
May 7, 2014 9:20 am EDT
OPKO Creates Global Supply Chain Structure
May 6, 2014 9:17 am EDT
OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEE™
Apr 22, 2014 3:06 pm EDT
OPKO Announces Presentation of Data on Long-Acting Oxyntomodulin at Diabetes Conference
Apr 17, 2014 11:22 am EDT
OPKO Acquires Next Generation Dry Powder Inhaler to Treat Respiratory Disorders
Apr 3, 2014 12:33 pm EDT
OPKO Health Announces Key Executive Appointments for Renal Division
Apr 1, 2014 9:25 am EDT
OPKO Health Announces Executive Appointments
Mar 31, 2014 11:29 am EDT
OPKO Announces Launch of 4Kscore Test for Prostate Cancer
Mar 25, 2014 12:18 pm EDT
American Urological Association (AUA) Accepts 4Kscore Test Clinical Study for Plenary Presentation at 2014 Annual Meeting
Mar 3, 2014 6:19 pm EST
OPKO Announces Fourth Quarter and Full Year 2013 Results
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • …
  • Page 55
  • Next Pagearrow_forward
rss_feed News RSS

Sign up to receive company updates straight to your inbox.

Sign Up for Email Alerts

4400 Biscayne Boulevard
Miami, FL 33137

305-575-4100 / contact@opko.com

©2026 OPKO Health, Inc. All Rights Reserved.
  • Privacy Policy
  • Terms Of Use
  • Sitemap
  • Accessibility Statement
  • Consent Preferences